NM_006892.4:c.1760-8C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006892.4(DNMT3B):​c.1760-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00394 in 1,614,126 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0040 ( 11 hom., cov: 33)
Exomes 𝑓: 0.0039 ( 89 hom. )

Consequence

DNMT3B
NM_006892.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00003183
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.14

Publications

3 publications found
Variant links:
Genes affected
DNMT3B (HGNC:2979): (DNA methyltransferase 3 beta) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq, May 2011]
DNMT3B Gene-Disease associations (from GenCC):
  • immunodeficiency-centromeric instability-facial anomalies syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency-centromeric instability-facial anomalies syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 20-32800145-C-T is Benign according to our data. Variant chr20-32800145-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 338174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.004 (609/152274) while in subpopulation AMR AF = 0.00333 (51/15306). AF 95% confidence interval is 0.00287. There are 11 homozygotes in GnomAd4. There are 285 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006892.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
NM_006892.4
MANE Select
c.1760-8C>T
splice_region intron
N/ANP_008823.1
DNMT3B
NM_175850.3
c.1736-8C>T
splice_region intron
N/ANP_787046.1
DNMT3B
NM_175848.2
c.1700-8C>T
splice_region intron
N/ANP_787044.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNMT3B
ENST00000328111.6
TSL:1 MANE Select
c.1760-8C>T
splice_region intron
N/AENSP00000328547.2
DNMT3B
ENST00000201963.3
TSL:1
c.1736-8C>T
splice_region intron
N/AENSP00000201963.3
DNMT3B
ENST00000348286.6
TSL:1
c.1700-8C>T
splice_region intron
N/AENSP00000337764.2

Frequencies

GnomAD3 genomes
AF:
0.00400
AC:
609
AN:
152156
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.0734
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00322
Gnomad OTH
AF:
0.00716
GnomAD2 exomes
AF:
0.00529
AC:
1330
AN:
251492
AF XY:
0.00530
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.0810
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.00334
Gnomad OTH exome
AF:
0.00896
GnomAD4 exome
AF:
0.00394
AC:
5755
AN:
1461852
Hom.:
89
Cov.:
30
AF XY:
0.00409
AC XY:
2974
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33480
American (AMR)
AF:
0.00152
AC:
68
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0797
AC:
2082
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00131
AC:
113
AN:
86256
European-Finnish (FIN)
AF:
0.000206
AC:
11
AN:
53418
Middle Eastern (MID)
AF:
0.00902
AC:
52
AN:
5768
European-Non Finnish (NFE)
AF:
0.00264
AC:
2939
AN:
1111988
Other (OTH)
AF:
0.00768
AC:
464
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
321
642
962
1283
1604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00400
AC:
609
AN:
152274
Hom.:
11
Cov.:
33
AF XY:
0.00383
AC XY:
285
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41534
American (AMR)
AF:
0.00333
AC:
51
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0734
AC:
255
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4816
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00322
AC:
219
AN:
68032
Other (OTH)
AF:
0.00709
AC:
15
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
11
Bravo
AF:
0.00447
EpiCase
AF:
0.00414
EpiControl
AF:
0.00450

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency (1)
-
-
1
DNMT3B-related disorder (1)
-
-
1
Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.29
DANN
Benign
0.46
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000032
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2424926; hg19: chr20-31387951; API